Recently, Pfizer whistleblower Melissa Strickler, a manufacturing quality auditor for the company, exposed some of their internal emails. She was horrified by the information they contained and spoke with Project Veritas about what she had uncovered – the use of fetal cells from aborted babies to test their COVID-19 vaccine. This is some of what top management wrote:
“From the perspective of corporate affairs,” [Pfizer Senior Director of Worldwide Research Vanessa] Gelman wrote in one email, “we want to avoid having the information on fetal cells floating out there … The risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want out there.
In another email exchange between Advait Badkar, senior director of the Novel Delivery Technologies group within Pfizer’s Biotherapeutics Pharmaceutical Sciences organization, Gelman can be seen admitting to Badkar that, “One or more cell lines with an origin that can be traced back to human fetal tissue has been used in laboratory tests associated with the vaccine program.”
She warned him that, “We have been trying as much as possible to not mention the fetal cell lines.”
Project Veritas attempted to speak with Gelman. This was her response (If the video clip is removed from YouTube you can view it on Project Veritas’ Telegram Channel here.):
Keine Kommentare:
Kommentar veröffentlichen